ArticleScientific reports2025
Antibacterial, self-healing, and pH-responsive PVA/ZIF-8@tannic acid nanocomposite hydrogel for sustained delivery of garlic extract.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Mesenchymal Stem Cell-Lysate Sustained-Release Nano-Hydrogel Alleviates Spinal Cord Injury by Inhibiting Ferroptosis and Mitochondrial Intrinsic Apoptosis.International dental journal · 2026Article
- Cellulose-Based Hydrogels for Chronic Wound Healing: Bridging Biomaterial Design and Clinical Unmet Needs.Gels (Basel, Switzerland) · 2026Review
- Self-assembling nanocomposites for smart drug delivery: towards personalized and stimuli-responsive therapeutics.RSC advances · 2026Review
- Biofilm-Responsive Nanoplatforms for Infected Wound Reconstruction.International journal of nanomedicine · 2026Review
- Stem Cells to Organoids: Pioneering the Future of Regenerative Therapies.Stem cell reviews and reports · 2026Review
- Hydrogel Films in Biomedical Applications: Fabrication, Properties and Therapeutic Potential.Gels (Basel, Switzerland) · 2025Review
- Exo-hydrogel therapy: a revolutionary approach to managing diabetic complications.Journal of nanobiotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrogels are increasingly recognized in biological research due to their unique characteristics and broad potential applications. In this study, a pH-responsive hydrogel-based nanocomposite was designed with antibacterial activity and self-healing ability, highlighting its promising applications in biomedical engineering and materials science. The hydrogel-based nanocomposite consists of a polyvinyl alcohol (PVA) hydrogel crosslinked with borax (PB), zinc-based zeolitic imidazolate framework-8 nanoparticles modified with tannic acid (ZIF-8@TA), and garlic extract. The pH-responsiveness of the hydrogel arises from ZIF-8@TA and borax, which undergoes controlled degradation in acidic and basic conditions, enabling the targeted release of zinc ions beneficial for infected wounds. Its physicochemical and mechanical properties, self-healing abilities, and rheological behavior have been thoroughly investigated. The antimicrobial efficacy, antioxidant activity, biocompatibility, and release of zinc and sulfur ions were also evaluated. Mechanical analysis demonstrates tensile strengths ranging from 109 to 353 kPa, highlighting the material's versatility and suitability for applications such as wound dressings. Additionally, the hydrogels exhibited healing efficiencies ranging from 65.45 to 85.27% across samples with varying ZIF-8@TA concentrations (5-15 wt%). Antibacterial studies of hydrogels (0.5 g/mL) demonstrated 100% bacterial inhibition against Escherichia coli and Staphylococcus aureus strains, while significant antioxidant activity and sustained release of zinc and sulfur ions were observed over a 15-day period. These findings make the ZIF-8@TA-modified PVA hydrogel a promising candidate for advanced biomedical applications, addressing challenges in infection management, tissue regeneration, and adaptability to diverse wound environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.